Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development

SF Zhou, ZW Zhou, LP Yang… - Current medicinal …, 2009 - ingentaconnect.com
Cytochrome P450 2C9 (CYP2C9) is one of the most abundant CYP enzymes in the human
liver. CYP2C9 metabolizes more than 100 therapeutic drugs, including tolbutamide …
被引用次数：239 相关文章

Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.

SF Zhou, ZW Zhou, LP Yang, JP Cai - Current Medicinal Chemistry, 2009 - europepmc.org
Cytochrome P450 2C9 (CYP2C9) is one of the most abundant CYP enzymes in the human
liver. CYP2C9 metabolizes more than 100 therapeutic drugs, including tolbutamide …

Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development

SF Zhou, ZW Zhou, LP Yang… - Current medicinal …, 2009 - pubmed.ncbi.nlm.nih.gov
Cytochrome P450 2C9 (CYP2C9) is one of the most abundant CYP enzymes in the human
liver. CYP2C9 metabolizes more than 100 therapeutic drugs, including tolbutamide …

[引用][C] Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development

SF ZHOU, ZW ZHOU, LP YANG… - Current medicinal …, 2009 - pascal-francis.inist.fr
Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome
P450 2C9 and Implications in Drug Development CNRS Inist Pascal-Francis CNRS Pascal …

Substrates, inducers, inhibitors and structure-activity relationships of human cytochrome P450 2C9 and implications in drug development

S Zhou, ZW Zhou, LP Yang… - Current Medicinal …, 2009 - researchrepository.rmit.edu.au
Cytochrome P450 2C9 (CYP2C9) is one of the most abundant CYP enzymes in the human
liver. CYP2C9 metabolizes more than 100 therapeutic drugs, including tolbutamide …

Substrates, inducers, inhibitors and structure-activity relationships of human cytochrome P450 2C9 and implications in drug development

SF Zhou, ZW Zhou, LP Yang… - Current …, 2009 - utsouthwestern.elsevierpure.com
Abstract Cytochrome P450 2C9 (CYP2C9) is one of the most abundant CYP enzymes in the
human liver. CYP2C9 metabolizes more than 100 therapeutic drugs, including tolbutamide …

Substrates, inducers, inhibitors and structure-activity relationships of human cytochrome P450 2C9 and implications in drug development

S Zhou, ZW Zhou, LP Yang… - Current Medicinal …, 2009 - researchrepository.rmit.edu.au
Cytochrome P450 2C9 (CYP2C9) is one of the most abundant CYP enzymes in the human
liver. CYP2C9 metabolizes more than 100 therapeutic drugs, including tolbutamide …

[引用][C] Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development

SF ZHOU, ZW ZHOU, LP YANG, JP CAI - Current medicinal chemistry, 2009 - Bentham